Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

Pediatrics - 1 Jun 1997

Gregg R G, Simantel A, Farrell P M, Koscik R, Kosorok M R, Laxova A, Laessig R, Hoffman G, Hassemer D, Mischler E H, Splaingard M

Abstract excerpt

OBJECTIVES: To evaluate neonatal screening for cystic fibrosis (CF), including study of the screening procedures and characteristics of false-positive infants, over the past 10 years in Wisconsin. An important objective evolving from the original design has been to compare use of a single-tier immunoreactive trypsinogen (IRT) screening method with that of a two-tier method using IRT and analyses of samples for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CFTR gene

Share to Infant, Newborn

Share to Mutation

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 9164776
DOI: 10.1542/peds.99.6.819

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.PMID 9164776Read ↗

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.Semantic proximity Read ↗

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.Semantic proximity Read ↗

Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity.Semantic proximity Read ↗

Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.Semantic proximity Read ↗

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.Semantic proximity Read ↗

Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.Semantic proximity Read ↗

A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.Semantic proximity Read ↗

Refinement of newborn screening for cystic fibrosis with next generation sequencing.Semantic proximity Read ↗

Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.Semantic proximity Read ↗

Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.